Article Type
Article
Changed
Fri, 03/08/2019 - 09:30
Display Headline
Beta2-microglobulin amyloidosis in renal failure: Understanding this recently recognized condition
Author(s)
Jonathan Kay, MD
Article PDF
ccjm66_3-0145.pdf
Author and Disclosure Information

Jonathan Kay, MD
Section of Rheumatology, Lahey Clinic; assistant clinical professor of medicine, Harvard Medical School

 

Issue
Cleveland Clinic Journal of Medicine - 66(3)
Publications
Cleveland Clinic Journal of Medicine
Page Number
145-147
Sections
Medical Grand Rounds
Author(s)
Jonathan Kay, MD
Author(s)
Jonathan Kay, MD
Author and Disclosure Information

Jonathan Kay, MD
Section of Rheumatology, Lahey Clinic; assistant clinical professor of medicine, Harvard Medical School

 

Author and Disclosure Information

Jonathan Kay, MD
Section of Rheumatology, Lahey Clinic; assistant clinical professor of medicine, Harvard Medical School

 

Article PDF
ccjm66_3-0145.pdf
Article PDF
ccjm66_3-0145.pdf
Issue
Cleveland Clinic Journal of Medicine - 66(3)
Issue
Cleveland Clinic Journal of Medicine - 66(3)
Page Number
145-147
Page Number
145-147
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
Beta2-microglobulin amyloidosis in renal failure: Understanding this recently recognized condition
Display Headline
Beta2-microglobulin amyloidosis in renal failure: Understanding this recently recognized condition
Sections
Medical Grand Rounds
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media